Research Topics

STEPHEN HAMMES

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. pmc Uterine-specific loss of Tsc2 leads to myometrial tumors in both the uterus and lungs
    Hen Prizant
    Division of Endocrinology and Metabolism, Department of Medicine, University of Rochester Medical Center, Rochester, New York 14642, USA
    Mol Endocrinol 27:1403-14. 2013
  2. pmc Minireview: Recent advances in extranuclear steroid receptor actions
    Stephen R Hammes
    Department of Medicine, University of Rochester, Rochester, New York 14642, USA
    Endocrinology 152:4489-95. 2011
  3. pmc GPCR/EGFR cross talk is conserved in gonadal and adrenal steroidogenesis but is uniquely regulated by matrix metalloproteinases 2 and 9 in the ovary
    Liliana Carbajal
    Division of Endocrinology and Metabolism, Department of Medicine, University of Rochester Medical Center, Rochester, New York 14642, USA
    Mol Endocrinol 25:1055-65. 2011

Research Grants

Collaborators

  • Hen Prizant
  • Liliana Carbajal
  • John P Lydon
  • Sung Nam Cho
  • Allison Light
  • Aritro Sen
  • Francesco J DeMayo
  • Anindita Biswas
  • Lisa M Niswander

Detail Information

Publications3

  1. pmc Uterine-specific loss of Tsc2 leads to myometrial tumors in both the uterus and lungs
    Hen Prizant
    Division of Endocrinology and Metabolism, Department of Medicine, University of Rochester Medical Center, Rochester, New York 14642, USA
    Mol Endocrinol 27:1403-14. 2013
    ..This mouse model may improve our understanding of LAM and leiomyomas and might lead to novel therapeutic strategies for both diseases. ..
  2. pmc Minireview: Recent advances in extranuclear steroid receptor actions
    Stephen R Hammes
    Department of Medicine, University of Rochester, Rochester, New York 14642, USA
    Endocrinology 152:4489-95. 2011
    ....
  3. pmc GPCR/EGFR cross talk is conserved in gonadal and adrenal steroidogenesis but is uniquely regulated by matrix metalloproteinases 2 and 9 in the ovary
    Liliana Carbajal
    Division of Endocrinology and Metabolism, Department of Medicine, University of Rochester Medical Center, Rochester, New York 14642, USA
    Mol Endocrinol 25:1055-65. 2011
    ..These results may have implications with regard to EGFR inhibitor use in various cancers as well as in polycystic ovarian syndrome, where excess LH-driven ovarian androgen production might be controlled by MMP2/9 inhibition...

Research Grants13

  1. Nongenomic Signaling by Steroids at the Cell Membrane
    STEPHEN HAMMES; Fiscal Year: 2002
    ....
  2. Nongenomic Signaling by Steroids at the Cell Membrane
    STEPHEN HAMMES; Fiscal Year: 2006
    ....
  3. Nongenomic Signaling by Steroids at the Cell Membrane
    STEPHEN HAMMES; Fiscal Year: 2005
    ....
  4. Nongenomic Signaling by Steroids at the Cell Membrane
    STEPHEN HAMMES; Fiscal Year: 2004
    ....
  5. Nongenomic Signaling by Steroids at the Cell Membrane
    STEPHEN HAMMES; Fiscal Year: 2003
    ....
  6. Nongenomic Signaling by Steroids at the Cell Membrane
    STEPHEN HAMMES; Fiscal Year: 2004
    ....
  7. Nongenomic Signaling by Steroids at the Cell Membrane
    STEPHEN HAMMES; Fiscal Year: 2005
    ....
  8. Nongenomic Steroid Signaling in Oocytes
    STEPHEN HAMMES; Fiscal Year: 2007
    ..These studies should lead to significant contributions in the fields of steroid receptor and G protein-mediated signaling, MAPK signaling and protein translation, as well as in the fields of meiosis and ovarian function. ..
  9. Nongenomic Signaling by Steroids at the Cell Membrane
    STEPHEN HAMMES; Fiscal Year: 2003
    ....
  10. Nongenomic Steroid Signaling in Oocytes
    STEPHEN HAMMES; Fiscal Year: 2009
    ..These studies should lead to significant contributions in the fields of steroid receptor and G protein-mediated signaling, MAPK signaling and protein translation, as well as in the fields of meiosis and ovarian function. ..